Breast Cancer Patients Receiving Anthracycline Chemotherapy and Trastuzumab Have Biventricular Dysfunction and Reduced Heart Mass

J Am Coll Cardiol. 2018 Oct 9;72(15):1872-1873. doi: 10.1016/j.jacc.2018.07.057.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anthracyclines / adverse effects*
  • Anthracyclines / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cardiac Imaging Techniques / methods*
  • Female
  • Humans
  • Myocardium / pathology
  • Organ Size / drug effects
  • Trastuzumab / adverse effects*
  • Trastuzumab / therapeutic use
  • Ventricular Dysfunction* / chemically induced
  • Ventricular Dysfunction* / diagnosis
  • Ventricular Dysfunction* / physiopathology

Substances

  • Anthracyclines
  • Antineoplastic Agents
  • Trastuzumab